SCHEMBL29910188

SCHEMBL29910188

Cn1c(=O)c2[nH]c(-c3cccnc3Cl)nc2n(-c2ccc(Cl)cc2)c1=O

nearest known ligand 0.60

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ADORA1 P30542 2/20 0.60
▸ ALDH1A1 P00352 3/20 0.50
▸ KDM4E B2RXH2 3/20 0.50
▸ HPGD P15428 2/20 0.50
▸ TDP1 Q9NUW8 1/20 0.50
▸ HSD17B10 Q99714 2/20 0.46
▸ USP2 O75604 1/20 0.46
▸ ADORA2B P29275 2/20 0.45
▸ TSHR P16473 2/20 0.44
▸ CYP1A2 P05177 1/20 0.43
▸ ADORA3 P0DMS8 1/20 0.43
▸ ADORA2A P29274 1/20 0.43
▸ BLM P54132 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ MEN1 O00255 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ PDE5A O76074 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25090480 0.71 ALDH1A1 (0.64) ADORA1ALDH1A1KDM4EHPGDTDP1
SCHEMBL25089896 0.71 ALDH1A1 (0.62) ADORA1ALDH1A1KDM4EHPGDTDP1
SCHEMBL23145941 0.70 ALDH1A1 (0.41) ADORA1ALDH1A1KDM4EHPGDTSHR
SCHEMBL2119734 0.69 KDM4E (0.72) ADORA1ALDH1A1KDM4EHPGDTDP1
SCHEMBL515588 0.69 KDM4E (0.76) ADORA1ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL8830756 0.68 ADORA2B (0.57) ADORA1ALDH1A1KDM4EHPGDTDP1
SCHEMBL25090647 0.68 KDM4E (0.62) ADORA1ALDH1A1KDM4EHPGDTDP1
SCHEMBL8830622 0.67 ADORA2B (0.56) ADORA1ALDH1A1KDM4EHPGDTDP1
SCHEMBL10614178 0.67 KDM4E (1.00) ADORA1ALDH1A1KDM4EHPGDTDP1
SCHEMBL20652968 0.67 ADORA1 (0.53) ADORA1ALDH1A1KDM4EHPGDTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114727983-A Xanthine CB1 inhibitors 金翅雀生物公司 2022-07-08 — — CN disclosed
Send feedback